Quantcast

Latest lidocaine Stories

2011-08-31 23:35:05

Computer-based simulations solve decades-old mystery of failed anti-arrhythmia therapy UC Davis researchers have developed an accurate computer model to test the effects of medications for arrhythmia, or abnormal heart rhythm, before they are used in patients. The new tool -- described in the Aug. 31 issue of the journal Science Translational Medicine -- will help scientists screen anti-arrhythmia medications early in the drug-development pipeline and eventually guide physicians in...

2011-08-10 15:00:00

MISSISSAUGA, ON, Aug. 10, 2011 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the second quarter ended June 30, 2011. Second Quarter and Recent Corporate Developments: -- Completed the acquisition of ZARS Pharma, Inc. (ZARS), creating...

2011-08-09 00:00:30

Absorption Pharmaceuticals' new corporate name aligns with its core technology - transdermal absorption of pharmaceutical agents. PROMESCENT, Absorption Pharmaceuticals' topical spray for premature ejaculation, enables users to quickly deliver controllable amounts of lidocaine to the dermis and subcutis/hypodermis in order to reduce senstivity of the penis and delay ejaculation. (PRWEB) August 07, 2011 The developers of the leading over-the-counter topical treatment for premature...

2011-06-28 13:00:00

MISSISSAUGA, ON, June 28, 2011 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.  NRI-ANA is being developed for...

2011-03-21 07:29:11

(Ivanhoe Newswire)-- There may be a new "it" drug on the market-- and it might be completely legal. After the drug "miaow miaow," or mephedrone, was banned in England in April of 2010, a new drug called "ivory wave" has risen to prominence to take its place. Though an article in Emergency Medical Journal claims it is as yet unclear if it contains illegal ingredients, ivory wave has been implicated in hospital admissions and deaths throughout England. Ivory wave, which also goes by the names...

2011-02-15 00:00:00

The number one objection voiced by the male to having a vasectomy done is the fear of pain. The Madajet lidocaine injector offers technology that allows for the painless infiltration of aneshesia without a needle. By offering the "No needle-No scalpel technique for a vasectomy, the urologists of the Northeast Georgia Urological Associates eliminate not only the fear associated with having a vasectomy but also the pain associated with the procedure. They take their motto concerning having a...

2010-11-11 07:00:00

FRANKLIN, Mass., Nov. 11, 2010 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude(TM) SkinPrep System for transdermal drug delivery, today announced that a 510(k) premarket notification has been submitted to the US Food and Drug Administration (FDA) for its Prelude SkinPrep System and 4% lidocaine cream. Market...

2010-08-24 07:00:00

FRANKLIN, Mass., Aug. 24 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude(TM) SkinPrep System for transdermal drug delivery, today announced the completion of a clinical study of Prelude. This clinical study was designed to evaluate the ability of Prelude to ablate the skin prior to the application of OTC...

2010-05-17 16:31:00

FRANKLIN, Mass., May 17 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, today announced financial results for the period ended March 31, 2010. Recent Corporate Highlights: In April, Echo Therapeutics and Ferndale Pharma Group initiated a...

2010-04-27 07:06:00

FRANKLIN, Mass., April 27 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, in collaboration with its strategic partner, Ferndale Pharma Group, Inc., announced today that the first patients were enrolled in a clinical study of its Prelude SkinPrep...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.